The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
General Medicine grows 5% and Vaccines 10% led by Shingrix
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)